e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Severe pulmonary infection and sepsis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Antibiotic therapy of the CAP at young patients from different social groups
H. V. Demchuk, Y. M. Mostovoy (Vinnytsia, Ukraine)
Source:
Annual Congress 2003 - Severe pulmonary infection and sepsis
Session:
Severe pulmonary infection and sepsis
Session type:
Thematic Poster Session
Number:
2865
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. V. Demchuk, Y. M. Mostovoy (Vinnytsia, Ukraine). Antibiotic therapy of the CAP at young patients from different social groups. Eur Respir J 2003; 22: Suppl. 45, 2865
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Antibiotic usage analysis of the community-acquired pneumonia at young patients from different social groups
Source: Eur Respir J 2003; 22: Suppl. 45, 149s
Year: 2003
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013
Therapeutic regimens in community acquired pneumonia (CAP): association with patients characteristics and outcomes
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Antimicrobial Treatment of CAP. Is there a higher benefit of macrolides combination in patients with pneumococcal CAP?
Source: International Congress 2017 – Update on community acquired pneumonia
Year: 2017
Influence of adherence to clinical guidelines in empiric antibiotics choice on outcomes of community-acquired pneumonia in hospitalized Belarussian patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study
Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia
Year: 2008
Antibiotic use in special populations: renal failure and the obese patient
Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections
Year: 2013
Antibiotic use in children with asthma
Source: International Congress 2017 – Small airways, long distances and large databases in paediatric asthma
Year: 2017
Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Preventive chemotherapy effectiveness in children and adolescents, contacting TB patients with DR TB strains
Source: Eur Respir J 2006; 28: Suppl. 50, 536s
Year: 2006
Optimising decision for antibiotic treatment in non-hospitalised CAP patient
Source: Virtual Congress 2020 – Antibiotic resistance: the way forward
Year: 2020
Changes in empirical initial antibiotic therapy in community-acquired pneumonia: assessment of clinical failure versus discordant therapy
Source: Eur Respir J 2006; 28: Suppl. 50, 736s
Year: 2006
Antibiotic preferences for childhood pneumonia vary by physician type and European region
Source: ERJ Open Res 2016: 00001-2016
Year: 2016
Effectiveness of treatment for MDR TB in children and adolescents
Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases
Year: 2007
Is tuberculosis different in elderly patients?
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007
Empirical antibiotic management of adult CAP
Source: Eur Respir Monogr 2014; 63: 140-154
Year: 2014
The effectiveness of MDR TB treatment in children and adolescents depending on its duration
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012
Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Costs of treatment of hospitalised community-acquired pneumonia from the hospitals’ perspective – a prospective study comparing moxifloxacin with other antibiotic treatment alternatives
Source: Eur Respir J 2004; 24: Suppl. 48, 185s
Year: 2004
The usage of laferon in treatment of patients with community acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept